Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Antibacterial gynecological gel capable of inhibiting human papillomavirus (HPV) and preparation method thereof

An HPV virus and gynecological technology, applied in the field of antibacterial gynecological gel and its preparation, can solve problems such as poor effect and insufficient bactericidal performance, and achieve the effect of good antibacterial effect, good viscosity and maintaining vaginal health

Inactive Publication Date: 2021-08-13
SHANGYU LIZI BIOTECH
View PDF6 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] Human papillomavirus (HPV) infection is the most important factor leading to cervical cancer, and most of the existing gynecological gels are mainly used for antibacterial and bactericidal, which are not effective in inhibiting HPV virus, and the bactericidal performance of the products is also insufficient

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Antibacterial gynecological gel capable of inhibiting human papillomavirus (HPV) and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0034] The present embodiment also provides a preparation method of antibacterial gynecological gel, comprising the following steps:

[0035] (1) dissolve the solubilizing agent in water, and add fulvic acid and silver ion antibacterial agent;

[0036] (2) Cationic fungicides, fullerenes, ginger root extracts, wampum bark extracts, Hypericum perforatum extracts, Artemisia spp. Mix with Scutellaria baicalensis root extract and dissolve in water;

[0037] (3) Mix the solutions obtained in step (1) and step (2) uniformly to obtain the antibacterial gynecological gel.

Embodiment 1

[0039] The antibacterial gynecological gel in the present embodiment comprises the following components in parts by weight: 2 parts of solubilizer, 0.5 part of fulvic acid, 0.5 part of silver ion antibacterial agent, 0.5 part of cationic bactericide, 0.5 part of fullerene, purified 88 parts of water, 1 part of Ginger root extract, 1 part of Pungaria extract, 1 part of Hypericum perforatum extract, 1 part of Artemisia perforatum extract, 1 part of Libido chinensis extract, 1 part of Sophora flavescens root extract, 1 part of Cnidium fruit extract, 1 part of Scutellaria baicalensis root extract.

[0040] Wherein, the solubilizing agent is glycerin, the cationic bactericide is chlorhexidine gluconate, and the silver ion antibacterial agent is a silver ion solution with a concentration of 10 mg / L.

[0041] The preparation steps are as follows:

[0042] (1) dissolve the solubilizing agent with water, and add fulvic acid and silver ion antibacterial agent;

[0043] (2) Cationic fu...

Embodiment 2

[0046] The antibacterial gynecological gel in the present embodiment comprises the following components in parts by weight: 2 parts of solubilizer, 0.5 part of fulvic acid, 0.5 part of silver ion antibacterial agent, 0.5 part of cationic bactericide, 0.5 part of fullerene, purified 88 parts of water, 1 part of Ginger root extract, 1 part of Pungaria extract, 1 part of Hypericum perforatum extract, 1 part of Artemisia perforatum extract, 1 part of Libido chinensis extract, 1 part of Sophora flavescens root extract, 1 part of Cnidium fruit extract, 1 part of Scutellaria baicalensis root extract.

[0047] Wherein, the solubilizer is glycerin, the cationic bactericide is amhexidine acetate, and the silver ion antibacterial agent is a silver ion solution with a concentration of 20 mg / L.

[0048] The preparation steps are as follows:

[0049] (1) dissolve the solubilizing agent in water, and add fulvic acid and silver ion antibacterial agent;

[0050] (2) Cationic fungicides, full...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Concentrationaaaaaaaaaa
Login to View More

Abstract

The invention discloses antibacterial gynecological gel capable of inhibiting a human papillomavirus (HPV). The antibacterial gynecological gel comprises the following ingredients in parts by weight: 1-3 parts of solubilizing agent, 0.5-1 part of fulvic acid, 0.5-1 part of silver ion antibacterial agent, 0.5-1 part of cationic bactericide, 0.05-0.5 part of fullerene, 80-90 parts of purified water, 0.5-2 parts of ginger root extract, 0.5-2 parts of phellodendron bark extract, 0.5-2 parts of hypericum perforatum extract and 0.5-2 parts of artemisia capillaris extract, 0.5-2 parts of radix stemonae extract, 0.5-2 parts of radix sophorae flavescentis extract, 0.5-2 parts of fructus cnidii extract and 0.5-2 parts of radix scutellariae extract. The antibacterial gynecological gel can prevent and treat female genital tract diseases caused by pathogenic bacteria, fungi and viruses, and has a good effect in the aspect of inhibiting the HPV. Multiple bactericides synergistically exert an antibacterial effect, so that the gel has a good antibacterial effect, also has a killing effect on staphylococcus aureus, candida albicans, escherichia coli and the like, and has a good antibacterial effect.

Description

technical field [0001] The invention belongs to the field of medicine, and relates to an antibacterial gynecological gel capable of inhibiting HPV virus and a preparation method thereof. Background technique [0002] Gynecological gel is a kind of gel, which has anti-inflammatory, bactericidal and antipruritic effects. It is a gynecological drug for the treatment of various gynecological vaginitis and cervicitis, such as bacterial vaginosis, trichomonal vaginitis, mixed vagina Inflammation, gonococcal infection, chronic cervicitis, cervical erosion, etc. Gynecological gel has obvious inhibitory effect on the growth of Staphylococcus aureus, Escherichia coli, Neisseria gonorrhoeae, Candida albicans, fungi, yeast and other pathogenic microorganisms. [0003] The existing patent application document with publication number CN110151684A describes an antibacterial gynecological gel and its preparation method and application. The antibacterial gynecological gel includes the follo...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/9068A61K9/06A61K47/10A61P31/20A61P31/02A61P31/04A61P31/10A61P15/00A61K35/02A61K33/38A61K31/155A61K31/785A61K33/44
CPCA61K35/02A61K33/38A61K31/155A61K31/785A61K33/44A61K36/9068A61K36/75A61K36/38A61K36/282A61K36/904A61K36/489A61K36/234A61K36/539A61K9/06A61K9/0034A61K47/10A61P31/20A61P31/02A61P31/04A61P31/10A61P15/00A61K2300/00Y02A50/30
Inventor 陈剑谷陈哲晖
Owner SHANGYU LIZI BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products